Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic Agent
- 16 April 1981
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (16) , 934-939
- https://doi.org/10.1056/nejm198104163041603
Abstract
Anticoagulation during hemodialysis is necessary to prevent clotting of the blood on contact with the dialysis membrane. Heparin is the usual anticoagulant used, but systemic anticoagulation may persist for hours, and hemorrhage is common.This publication has 12 references indexed in Scilit:
- Complications in hemodialysis: An overviewKidney International, 1980
- Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparinKidney International, 1979
- Replacement of Renal Function by DialysisPublished by Springer Nature ,1979
- PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGSThe Lancet, 1978
- Spontaneous Retroperitoneal Bleeding in Patients on Chronic HemodialysisAnnals of Internal Medicine, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Hemorrhagic Pleural Effusion in Patients Undergoing Chronic HemodialysisAnnals of Internal Medicine, 1975
- Subdural hematoma associated with long-term hemodialysis for chronic renal diseasePublished by American Medical Association (AMA) ,1970
- Uremic hemopericardiumThe American Journal of Medicine, 1968
- Anticoagulation Rebound after HemodialysisNew England Journal of Medicine, 1966